Ongoing coughing; Extreme dizziness; Swelling of upper airway (lips,tongue, throat, uvula, or larynx); Sensation of throat closing; Red/itchy eyes; Red/itchy eyes; Sneezing/runny nose; Difficulty breathing/Use of respiratory accessory muscles; Bronchospasm /wheezing; Bronchospasm /wheezing; Hoarseness; Chest tightness; Cyanosis; sleep apnea; Reactive Airway Disease; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Ongoing coughing), DIZZINESS (Extreme dizziness), CIRCUMORAL SWELLING (Swelling of upper airway (lips,tongue, throat, uvula, or larynx)), OROPHARYNGEAL DISCOMFORT (Sensation of throat closing) and EYE PRURITUS (Red/itchy eyes) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Coronary artery disease since 2007, Hay fever, Asthma, Hypothyroidism (Levothyroxine increase to 112 mcg), BPH, Blood pressure and Hyperlipidemia. Concomitant products included TAMSULOSIN for BPH, AMLODIPINE for Blood pressure, ATORVASTATIN for Hyperlipidemia, LEVOTHYROXINE for Hypothyroidism, FINASTERIDE for Prostate infection.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced COUGH (Ongoing coughing), DIZZINESS (Extreme dizziness), CIRCUMORAL SWELLING (Swelling of upper airway (lips,tongue, throat, uvula, or larynx)), OROPHARYNGEAL DISCOMFORT (Sensation of throat closing), EYE PRURITUS (Red/itchy eyes), OCULAR HYPERAEMIA (Red/itchy eyes), SNEEZING (Sneezing/runny nose), DYSPNOEA (Difficulty breathing/Use of respiratory accessory muscles), BRONCHOSPASM (Bronchospasm /wheezing), WHEEZING (Bronchospasm /wheezing), DYSPHONIA (Hoarseness), CHEST DISCOMFORT (Chest tightness), CYANOSIS (Cyanosis), SLEEP APNOEA SYNDROME (sleep apnea) and BRONCHIAL HYPERREACTIVITY (Reactive Airway Disease). The patient was treated with PREDNISONE in 2021 for Antihistamine therapy, at an unspecified dose and frequency; BENZONATATE for Antihistamine therapy, at an unspecified dose and frequency; SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA) at a dose of 2.3 mcg; OMEPRAZOLE at an unspecified dose and frequency and AZELASTINE HCL at a dose of 0.1 UNK. At the time of the report, COUGH (Ongoing coughing), DIZZINESS (Extreme dizziness), CIRCUMORAL SWELLING (Swelling of upper airway (lips,tongue, throat, uvula, or larynx)), OROPHARYNGEAL DISCOMFORT (Sensation of throat closing), EYE PRURITUS (Red/itchy eyes), OCULAR HYPERAEMIA (Red/itchy eyes), SNEEZING (Sneezing/runny nose), DYSPNOEA (Difficulty breathing/Use of respiratory accessory muscles), BRONCHOSPASM (Bronchospasm /wheezing), WHEEZING (Bronchospasm /wheezing), DYSPHONIA (Hoarseness), CHEST DISCOMFORT (Chest tightness), CYANOSIS (Cyanosis), SLEEP APNOEA SYNDROME (sleep apnea) and BRONCHIAL HYPERREACTIVITY (Reactive Airway Disease) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Chest X-ray: normal normal. On an unknown date, Electrocardiogram: normal normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It had been stated that Last urgent care visit on 28-MAY-2021 his condition is listed as Reactive Airway Disease. Patient went to urgent care and was prescribed an antibiotic. CPAP for severe sleep apnea   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Follow up received on 29-MAY-2021 contain significant information included Patient medical history updated, Information on suspect drug, concomitant medication history included. Additional events are added.